| S7795 |
Ladademstat (ORY-1001) Dihydrochloride
|
ORY-1001 (RG-6016) 2HCl is an orally active and selective lysine-specific demethylase LSD1/KDM1A inhibitor with IC50 of <20 nM, with high selectivity against related FAD dependent aminoxidases. Phase 1.
|
-
EMBO Rep, 2025, 10.1038/s44319-025-00385-w
-
Nat Commun, 2024, 15(1):5631
-
Cell Death Discov, 2024, 10(1):166
|
|
| S7237 |
OG-L002
|
OG-L002 is a potent and specific LSD1 inhibitor with IC50 of 20 nM in a cell-free assay, exhibiting 36- and 69-fold selectivity over MAO-B and MAO-A, respectively.
|
-
Cancer Res Commun, 2025, 5(9):1584-1598
-
bioRxiv, 2025, 2025.06.20.660795
-
Cell Death Discov, 2024, 10(1):166
|
|